GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » Loans Receivable

Novomics Co (XKRX:283100) Loans Receivable : ₩0.0 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Novomics Co Loans Receivable?

Novomics Co's Loans Receivable for the quarter that ended in Dec. 2023 was ₩0.0 Mil.


Novomics Co Loans Receivable Historical Data

The historical data trend for Novomics Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novomics Co Loans Receivable Chart

Novomics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial - - - - -

Novomics Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable Get a 7-Day Free Trial - - - - -

Novomics Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Novomics Co Loans Receivable Related Terms

Thank you for viewing the detailed overview of Novomics Co's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Novomics Co Business Description

Traded in Other Exchanges
N/A
Address
171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co Headlines

No Headlines